News and Views.
- Published in:
- Diabetes, Obesity & Metabolism, 2012, v. 14, n. 3, p. 288, doi. 10.1111/j.1463-1326.2012.01578.x
- By:
- Publication type:
- Article
Works in Diabetes, Obesity & Metabolism, 2012, Vol 14, Issue 3
Results: 13
1
2
Effects of losartan on whole body, skeletal muscle and vascular insulin responses in obesity/insulin resistance without hypertension.
- Published in:
- Diabetes, Obesity & Metabolism, 2012, v. 14, n. 3, p. 254, doi. 10.1111/j.1463-1326.2011.01522.x
- By:
- Publication type:
- Article
3
The atypical cannabinoid O-1602 stimulates food intake and adiposity in rats.
- Published in:
- Diabetes, Obesity & Metabolism, 2012, v. 14, n. 3, p. 234, doi. 10.1111/j.1463-1326.2011.01515.x
- By:
- Publication type:
- Article
4
Comparisons of the effects of 12-week administration of miglitol and voglibose on the responses of plasma incretins after a mixed meal in Japanese type 2 diabetic patients.
- Published in:
- Diabetes, Obesity & Metabolism, 2012, v. 14, n. 3, p. 283, doi. 10.1111/j.1463-1326.2011.01526.x
- By:
- Publication type:
- Article
5
Optimizing weight gain in pregnancy to prevent obesity in women and children.
- Published in:
- Diabetes, Obesity & Metabolism, 2012, v. 14, n. 3, p. 195, doi. 10.1111/j.1463-1326.2011.01489.x
- By:
- Publication type:
- Article
6
Blockade of kinin B<sub>1</sub> receptor reverses plasma fatty acids composition changes and body and tissue fat gain in a rat model of insulin resistance.
- Published in:
- Diabetes, Obesity & Metabolism, 2012, v. 14, n. 3, p. 244, doi. 10.1111/j.1463-1326.2011.01521.x
- By:
- Publication type:
- Article
7
GPR40-induced insulin secretion by the novel agonist TAK-875: first clinical findings in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2012, v. 14, n. 3, p. 271, doi. 10.1111/j.1463-1326.2011.01525.x
- By:
- Publication type:
- Article
8
Do antidiabetic medications play a specific role in differentiated thyroid cancer compared to other cancer types?
- Published in:
- Diabetes, Obesity & Metabolism, 2012, v. 14, n. 3, p. 204, doi. 10.1111/j.1463-1326.2011.01491.x
- By:
- Publication type:
- Article
9
Soluble activin receptor type IIB treatment does not cause fat loss in mice with diet-induced obesity.
- Published in:
- Diabetes, Obesity & Metabolism, 2012, v. 14, n. 3, p. 279, doi. 10.1111/j.1463-1326.2011.01520.x
- By:
- Publication type:
- Article
10
Metabolic effects of bariatric surgery in type 2 diabetic patients with body mass index < 35 kg/m<sup>2</sup>.
- Published in:
- Diabetes, Obesity & Metabolism, 2012, v. 14, n. 3, p. 262, doi. 10.1111/j.1463-1326.2011.01524.x
- By:
- Publication type:
- Article
11
Intranasal administration of insulin to the brain impacts cognitive function and peripheral metabolism.
- Published in:
- Diabetes, Obesity & Metabolism, 2012, v. 14, n. 3, p. 214, doi. 10.1111/j.1463-1326.2011.01490.x
- By:
- Publication type:
- Article
12
Proportion of patients at HbA1c target <7% with eight classes of antidiabetic drugs in type 2 diabetes: systematic review of 218 randomized controlled trials with 78 945 patients.
- Published in:
- Diabetes, Obesity & Metabolism, 2012, v. 14, n. 3, p. 228, doi. 10.1111/j.1463-1326.2011.01512.x
- By:
- Publication type:
- Article
13
U-100, pH-Neutral formulation of VIAject<sup>®</sup>: faster onset of action than insulin lispro in patients with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2012, v. 14, n. 3, p. 222, doi. 10.1111/j.1463-1326.2011.01516.x
- By:
- Publication type:
- Article